Literature DB >> 17179773

Rising rates of syphilis in the era of syphilis elimination.

Roxanne P Kerani1, H Hunter Handsfield, Mark S Stenger, Taraneh Shafii, Ellen Zick, Devon Brewer, Matthew R Golden.   

Abstract

OBJECTIVE: The objective of this study was to assess the impact of syphilis control activities in King County, Washington. STUDY
DESIGN: We calculated rates of early syphilis and trends in numbers of persons tested and diagnosed through screening and partner notification from 1998 to 2005.
RESULTS: Early syphilis cases increased from 38 in 1998 to 188 in 2005 with 92% occurring among men who have sex with men (MSM). Our health department conducted public awareness campaigns, increased publicly financed syphilis screening among MSM by 179%, and intensified partner notification efforts. Despite these efforts, the prevalence of syphilis among screened populations was only 1.1%, and 71% syphilis cases were diagnosed after seeking care for symptoms. The proportion of cases diagnosed through screening and partner notification did not significantly change during the evaluation period. Early syphilis incidence among MSM more than doubled between 2003 and 2005.
CONCLUSIONS: New, innovative approaches to syphilis control are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17179773     DOI: 10.1097/01.olq.0000233709.93891.e5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Needle in a haystack: the yield of syphilis outreach screening at 5 US sites-2000 to 2007.

Authors:  Felicia M T Lewis; Julia A Schillinger; Melanie Taylor; Toye H Brewer; Susan Blank; Tom Mickey; Bruce W Furness; Greta L Anschuetz; Melinda E Salmon; Thomas A Peterman
Journal:  J Public Health Manag Pract       Date:  2011 Nov-Dec

2.  The role of commercial sex venues in the HIV epidemic among men who have sex with men.

Authors:  William John Reidy; Steven Michael Goodreau
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

3.  Evaluation of test results of microbiology laboratories of North India for standard tests for syphilis under an external quality assurance scheme.

Authors:  S M Gupta; M Bala; S Muralidhar; K Ray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-01       Impact factor: 3.267

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  Functional clues from the crystal structure of an orphan periplasmic ligand-binding protein from Treponema pallidum.

Authors:  Chad A Brautigam; Ranjit K Deka; Wei Z Liu; Diana R Tomchick; Michael V Norgard
Journal:  Protein Sci       Date:  2017-03-23       Impact factor: 6.725

6.  Improving partner services by embedding disease intervention specialists in HIV-clinics.

Authors:  Melanie M Taylor; Tom Mickey; Michelle Winscott; Heather James; Kerry Kenney; Bob England
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

7.  Posterior placoid chorioretinitis: An unusual ocular manifestation of syphilis.

Authors:  Jennifer Chen; Lawrence Lee
Journal:  Clin Ophthalmol       Date:  2008-09

8.  Identifying syphilis risk networks through venue attendance in San Francisco.

Authors:  Sally C Stephens; Charles K Fann; Frank V Strona; Wendy Wolf; Stephanie E Cohen; Susan S Philip; Kyle T Bernstein
Journal:  Sex Transm Dis       Date:  2014-05       Impact factor: 2.830

9.  Structural and biochemical basis for polyamine binding to the Tp0655 lipoprotein of Treponema pallidum: putative role for Tp0655 (TpPotD) as a polyamine receptor.

Authors:  Mischa Machius; Chad A Brautigam; Diana R Tomchick; Patrick Ward; Zbyszek Otwinowski; Jon S Blevins; Ranjit K Deka; Michael V Norgard
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

10.  Screen more or screen more often? Using mathematical models to inform syphilis control strategies.

Authors:  Ashleigh R Tuite; David N Fisman; Sharmistha Mishra
Journal:  BMC Public Health       Date:  2013-06-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.